A newly discovered genetic condition caused by faulty protein synthesis which causes delayed development and learning difficulties could be treated
Read moreHome »
Why it’s too soon for Australia to legalize ecstasy and magic mushrooms to treat mental illness
While the public focus remains on COVID vaccines, the Therapeutic Goods Administration (TGA) continues to evaluate a range of proposals
Read moreEnhanced scorpion venom molecules can be used to treat Chagas disease
Animal toxins are research targets owing to their therapeutic and biotechnological potential. Researchers at the Federal University of the ABC
Read moreNew compound related to psychedelic ibogaine could treat addiction, depression
A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been
Read moreCanadian team first in world to treat COVID-19 with specialized dialysis
As part of a randomized controlled trial, a team from Lawson Health Research Institute is the first in the world
Read moreCalquence approved to treat CLL, SLL
(HealthDay)—The U.S. Food and Drug Administration has granted supplemental approval to Calquence (acalabrutinib) for treatment of chronic lymphocytic leukemia (CLL)
Read moreDrug approved to treat tenosynovial giant cell tumor
(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and
Read moreVaccine developed to treat osteoarthritic pain by blocking nerve growth factor
In a collaborative effort between the Jenner Institute and the Kennedy Institute of Rheumatology at the University of Oxford, with
Read moreStudy identifies new target to prevent, treat alcoholism
New research conducted at OHSU in Portland, Oregon, identifies a gene that could provide a new target for developing medication
Read more